BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 30378081)

  • 1. In Silico Oncology Drug Repositioning and Polypharmacology.
    Cheng F
    Methods Mol Biol; 2019; 1878():243-261. PubMed ID: 30378081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico polypharmacology of natural products.
    Fang J; Liu C; Wang Q; Lin P; Cheng F
    Brief Bioinform; 2018 Nov; 19(6):1153-1171. PubMed ID: 28460068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polypharmacology in Precision Oncology: Current Applications and Future Prospects.
    Antolin AA; Workman P; Mestres J; Al-Lazikani B
    Curr Pharm Des; 2016; 22(46):6935-6945. PubMed ID: 27669965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting targeted polypharmacology for drug repositioning and multi- target drug discovery.
    Liu X; Zhu F; Ma XH; Shi Z; Yang SY; Wei YQ; Chen YZ
    Curr Med Chem; 2013; 20(13):1646-61. PubMed ID: 23410165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposing Drugs in Oncology: Next Steps.
    Verbaanderd C; Meheus L; Huys I; Pantziarka P
    Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico prediction of chemical mechanism of action via an improved network-based inference method.
    Wu Z; Lu W; Wu D; Luo A; Bian H; Li J; Li W; Liu G; Huang J; Cheng F; Tang Y
    Br J Pharmacol; 2016 Dec; 173(23):3372-3385. PubMed ID: 27646592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational polypharmacology: a new paradigm for drug discovery.
    Chaudhari R; Tan Z; Huang B; Zhang S
    Expert Opin Drug Discov; 2017 Mar; 12(3):279-291. PubMed ID: 28067061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SDTNBI: an integrated network and chemoinformatics tool for systematic prediction of drug-target interactions and drug repositioning.
    Wu Z; Cheng F; Li J; Li W; Liu G; Tang Y
    Brief Bioinform; 2017 Mar; 18(2):333-347. PubMed ID: 26944082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy.
    Fang J; Wu Z; Cai C; Wang Q; Tang Y; Cheng F
    J Chem Inf Model; 2017 Nov; 57(11):2657-2671. PubMed ID: 28956927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
    Palve V; Liao Y; Remsing Rix LL; Rix U
    Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology.
    Wathieu H; Issa NT; Byers SW; Dakshanamurthy S
    Curr Pharm Des; 2016; 22(21):3097-108. PubMed ID: 26907947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational drug repositioning for cancer therapeutics.
    Jiao M; Liu G; Xue Y; Ding C
    Curr Top Med Chem; 2015; 15(8):767-75. PubMed ID: 25732789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Advances in In Silico Target Fishing.
    Galati S; Di Stefano M; Martinelli E; Poli G; Tuccinardi T
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug2ways: Reasoning over causal paths in biological networks for drug discovery.
    Rivas-Barragan D; Mubeen S; Guim Bernat F; Hofmann-Apitius M; Domingo-Fernández D
    PLoS Comput Biol; 2020 Dec; 16(12):e1008464. PubMed ID: 33264280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tools for in silico target fishing.
    Cereto-Massagué A; Ojeda MJ; Valls C; Mulero M; Pujadas G; Garcia-Vallve S
    Methods; 2015 Jan; 71():98-103. PubMed ID: 25277948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems biology based drug repositioning for development of cancer therapy.
    Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
    Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.